Companies
Bio-Techne
S&P 500Health Care· USA

TECH

Status-Quo-Player

Bio-Techne

$57.53

+3.54%

Open $55.42·Prev $55.57

as of 13 Apr

STATUS-QUO-PLAYER

Power Core

The moat in one sentence: Bio-Techne's power derives from being the cited standard in biological reagents, where switching suppliers introduces scientific risk that researchers, journals, and regulators are structurally unwilling to accept.

Published1 Apr 2026
UniverseS&P 500
SectorHealth Care

Direction of Movement

Steady Core Recovery, Growth Segments Await Critical Mass

ROC 200

+2.9%

Referenced in 1 other analysis

Company Profile

Bio-Techne Corporation is a global developer, manufacturer and supplier of high-quality reagents, analytical instruments, and precision diagnostics serving the research, diagnostic, and bioprocessing markets worldwide. The company operates through two primary segments: protein sciences, which develops biological reagents including cytokines, growth factors, antibodies, and cell selection technologies; and diagnostics and spatial biology, which provides diagnostic reagents, molecular diagnostics, and spatial biology products. Bio-Techne maintains an extensive catalog of over 500,000 products, with approximately 95% manufactured in-house. Its portfolio includes flagship brands such as R&D Systems, Novus Biologicals, ProteinSimple, Advanced Cell Diagnostics, Asuragen, and Tocris Bioscience, serving academic research institutions, pharmaceutical and biotechnology companies, clinical diagnostic laboratories, and government agencies. Headquartered in Minneapolis, Minnesota, the company operates manufacturing facilities, research centers, and customer support offices across North America, Europe, and Asia-Pacific, generating significant revenue from the United States while maintaining a strong international presence. Bio-Techne's reputation for high-quality proteomic reagents and instruments enables it to maintain strong margins and cash flow while supporting scientific discovery and clinical breakthroughs.

Sector

Healthcare

Industry

Biotechnology

Employees

3,100

This page is for informational purposes only and does not constitute investment advice. L17X Research is an independent research service.